IPOs

A China biotech unicorn scores big with $150M-plus IPO on Nasdaq, stock rockets up
Endpoints
Fri, 09/22/17 - 09:07 am
China
biotech
IPOs
NASDAQ
Zai Labs
Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall
Endpoints
Wed, 09/6/17 - 10:37 am
Rhythm Pharmaceuticals
IPOs
obesity
rare disease
ASCO spotlight presaged two more biotech IPOs angling for $215M
Endpoints
Tue, 09/5/17 - 09:35 am
ASCO
IPOs
biotech
Deciphera
DCC-2618
Nucana
Acelarin
Peregrine slashes R&D in a reorg that claims 60 jobs; Zai Labs in hunt for $150M IPO – report
Endpoints
Sat, 08/12/17 - 11:53 am
Peregrine Pharmaceuticals
reorganization
Zai Labs
IPOs
Eyeing an IPO, Sutro retools its $1B I/O deal with Celgene but stays focused on BCMA
Endpoints
Thu, 08/10/17 - 11:37 am
IPOs
Sutro
Celgene
BCMA
Kala Pharmaceuticals prices $90m IPO
Drug Delivery Business News
Thu, 07/20/17 - 06:00 pm
Kala Pharmaceuticals
IPOs
cataract surgery
Ionis-spinout Akcea prices IPO below expected range
Drug Delivery Business News
Sat, 07/15/17 - 11:23 am
Akcea
Ionis
IPOs
Volanesorsen
Biotech IPOs more than double in Q2
BioPharma Dive
Fri, 07/7/17 - 02:37 pm
biotech
IPOs
BeyondSprings Therapeutics
Jounce Therapeutics
AnaptysBio
Another biotech IPO boasting a pharma castoff rings the bell on Wall Street with $75M haul
Endpoints
Thu, 06/29/17 - 02:22 pm
IPOs
biotech
Dova Pharmaceuticals
Mersana
Aileron
Akcea now shooting for $200M-plus as a new lineup of biotech IPOs prep for a launch
Endpoints
Tue, 06/20/17 - 09:51 am
Akcea
biotech
IPOs
Novartis
7 Things You Didn't Know About Gilead Sciences, Inc.
Motley Fool
Mon, 05/29/17 - 11:56 am
Gilead Sciences
GSK
cash flow
IPOs
Warren Buffett
Argenx IPO haul tops out at $115M, 50% above initial goal
Fierce Biotech
Tue, 05/23/17 - 08:06 am
Argenx
IPOs
G1 Therapeutics joins a growing biotech winners circle with $105M IPO
Endpoints
Wed, 05/17/17 - 09:47 am
G1 Therapeutics
IPOs
IPO Preview: Biohaven Pharmaceuticals
Seeking Alpha
Thu, 05/4/17 - 09:48 am
IPOs
Biohaven Pharmaceuticals
Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO
Endpoints
Tue, 04/18/17 - 08:58 pm
G1 Therapeutics
IPOs
Pfizer
Novartis
Eli Lilly
cancer
R&D
Biopharma IPOs sluggish in Q1. Will that continue?
BioPharma Dive
Thu, 04/13/17 - 06:41 pm
IPOs
AnaptysBio
Jounce Therapeutics
ObsEva
Valeritas
Candid Truths From A Biotech IPO
Endpoints
Fri, 04/7/17 - 09:52 am
biotech
IPOs
AnaptysBio
Tandem Diabetes Care prices $22.5m public offering
Drug Delivery Business News
Thu, 03/23/17 - 09:50 pm
IPOs
Tandem Diabetes
insulin pumps
diabetes
devices
Valeritas raises IPO stakes, looks for $60m
Mass Device
Sat, 03/18/17 - 09:29 am
Valeritas
IPOs
insulin delivery
devices
Biotech IPOs off to better start in 2017
BioPharma Dive
Fri, 02/3/17 - 10:12 am
biotech
IPOs
ObsEva
AnaptysBio
Jounce Therapeutics

Pages